Remove 2021 Remove Drug Development Remove healthcare technology Remove Telemedicine
article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Market Dynamics: Lower valuations: Compared to the heady days of 2021, HealthTech valuations have cooled down, making "soft landing" deals more attractive for both acquirers and targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.